Experimental models of spontaneous autoimmune disease in the central nervous system

Journal of Molecular Medicine

Volumn 85, Issue 11, 2007, Pages 1161-1173

  Krishnamoorthy, Gurumoorthy ^a   Holz, Andreas ^b   Wekerle, Hartmut ^a  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Animal models; Central nervous system; Multiple sclerosis; Spontaneous autoimmunity

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYTOKINE; T LYMPHOCYTE RECEPTOR;

ANTIBODY SPECIFICITY; ASTROCYTE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; DISEASE COURSE; EXPERIMENTAL MODEL; GENE MUTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; LYMPHOCYTE; MULTIPLE SCLEROSIS; MYELINATION; NERVE CELL; NERVOUS TISSUE; NEUROFILAMENT; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; REGULATOR GENE; REVIEW; SCREENING; TARGET CELL; THYMECTOMY; TRANSGENICS;

ANIMALS; AUTOIMMUNE DISEASES; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; RECEPTORS, ANTIGEN, T-CELL;

EID: 35448969346     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0218-x     Document Type: Review

References (108)

1. Hemachudha T, Griffin DE, Giffels JJ, Johnson RT, Moser AB, Phanuphak P (1987) Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med 316:369-374
2. Bach J-F (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911-920
3. Wekerle H, Lassmann H (2006) The immunology of inflammatory demyelinating disease. In: Compston A, Confavreux C, Lassmann H, McDonald I, Miller D, Noseworthy J, Smith K, Wekerle H (eds) McAlpine's multiple sclerosis. Elsevier, London, UK, pp 491-546
4. Compston A, Wekerle H (2006) The genetics of multiple sclerosis. In: Compston A, Confavreux C, Lassmann H, McDonald I, Miller D, Noseworthy J, Smith K, Wekerle H (eds) McAlpine's multiple sclerosis. Elsevier, London, UK, pp 113-181
5. Lam-Tse WK, Lernmark Å, Drexhage HA (2002) Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity? Springer Semin Immunopathol 24:297-321
6. Greiner DL, Rossini AA, Mordes JP (2001) Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor and primum non nocere. Cell Immunol 100:134-143
7. Anderson MS, Bluestone JA (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23:447-485
8. Todd JA, Wicker LS (2001) Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 15:387-395
9. Lesage S, Goodnow CC (2001) Organ specific autoimmune disease: a deficiency of tolerogenic stimulation? J Exp Med 194:F31-F36
10. Kojima A, Tanaka-Kojima Y, Sakakura T, Nishizuka Y (1976) Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab Invest 34:550-558
11. Sakaguchi S, Sakaguchi N (2000) Role of genetic factors in organ specific autoimmune diseases induced by manipulating the thymus or T cells, and not self-antigens. Rev Immunogenet 2:147-153
12. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531-562
13. Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y (1997) Identification of a-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 276:604-607
14. Alderuccio F, Toh B-H, Tan S-S, Gleeson PA, Van Driel IR (1993) An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus. J Exp Med 178:419-426
15. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253-261
16. Malek TR, Yu A, Vincek V, Scibelli P, Kong L (2002) CD4 regulatory T cells prevent lethal autoimmunity in IL-2R-deficient mice: implications for the nonredundant function of IL-2. Immunity 17:167-178
17. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko S-A, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27:68-73
18. + regulatory T cells. Nat Immunol 4:330-336
19. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057-1061
20. + T regulatory cells. Nat Immunol 4:337-342
21. Aaltonen J, Björses P, Sandkuijl L, Perheentupa J, Peltonen L (1994) An autosomal locus causing autoimmune disease. Autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet 8:83-87
22. Ramsey C, Winqvist O, Puhakka L, Halonen M, Moro A, Kampe O, Eskelin P, Pelto-Huikko M, Peltonen L (2002) AIRE deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 11:397-409
23. Derbinski J, Gäbler J, Brors B, Tierling S, Jonnakuty S, Hergenhahn M, Peltonen L, Walter J, Kyewski B (2005) Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med 202:33-45
24. Su MA, Anderson MS (2004) Aire: an update. Curr Opin Immunol 16:746-752
25. Mi Q-S, Deng Z-B, Joshi SK, Wang Z-Z, Zhou L, Eckenrode S, Joshi R, Ly D, Yi B, Delovitch TL et al (2006) The autoimmune regulator (Aire) controls iNKT cell development and maturation. Nat Med 12:624-626
26. Chen ZB, Benoist C, Mathis D (2005) How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci USA 102:14735-14740
27. Salomon B, Rhee L, Bour-Jordan H, Hsin H, Montag A, Soliven B, Arcella J, Girvin AM, Miller SD, Bluestone JA (2001) Development of spontaneous autoimmune peripheral polyneuropathy in B7-2 deficient NOD mice. J Exp Med 194:677-684
28. Bour-Jordan H, Thompson HL, Bluestone JA (2005) Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice. J Immunol 175:5649-5655
29. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201:723-735
30. Oono T, Fukui Y, Masuko S, Hashimoto O, Ueno T, Sanui T, Inayoshi A, Noda M, Sata M, Sasazuki T (2001) Organ-specific autoimmunity in mice whose T cell repertoire is shaped by a single antigenic peptide. J Clin Invest 108:1589-1596
31. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α. Proc Natl Acad Sci USA 92:11294-11298
32. Kassiotis G, Bauer J, Akassoglou K, Lassmann H, Kollias G, Probert L (1999) A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice. Eur J Immunol 29:912-917
33. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L (1993) Neurologic disease induced in transgenic mice by cerebral over-expression of interleukin 6. Proc Natl Acad Sci USA 90:10061-10065
34. Brett FM, Mizisin AP, Powell HC, Campbell IL (1995) Evolution of neuropathologic abnormalities associated with blood-brain-barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol 54:766-775
35. Chiang C-S, Powell HC, Gold LH, Samimi A, Campbell IL (1996) Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J Clin Invest 97:1512-1524
36. Akwa Y, Hassett DE, Eloranta M-L, Sandberg K, Masliah E, Powell HC, Whitton JL, Bloom FE, Campbell IL (1998) Transgenic expression of IFN-α in the central nervous system of mice protects against lethal neurotrophic viral infection but induces inflammation and neurodegeneration. J Immunol 161:5016-5026
37. Pagenstecher A, Lassmann S, Carson MJ, Kincaid CL, Stalder AK, Campbell IL (2000) Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis. J Immunol 164:4481-4492
38. Horwitz MS, Evans CF, McGavern DB, Rodriguez M, Oldstone MBA (1997) Primary demyelination in transgenic mice expressing interferon-γ. Nat Med 3:1037-1041
39. Harrington LE, Mangan PR, Weaver CT (2006) Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 18:349-356
40. Fuentes ME, Durham SK, Swerdel MR, Lewin AC, Barton DS, Megill JR, Bravo R, Lira SA (1995) Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 155:5769-5776
41. Boztug K, Carson MJ, Pham-Mitchell N, Asensio VC, DeMartino J, Campbell IL (2002) Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10. J Immunol 169:1505-1515
42. Griffin DE, Moser HW, Mendoza Q, Moensch TR, O'Toole S, Moser AB (1985) Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy. Ann Neurol 18:660-664
43. McGuinness MC, Powers JM, Bias WB, Schmeckpeper BJ, Segal AH, Gowda VC, Wesselingh SL, Berger J, Griffin DE, Smith KD (1997) Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinating lesions of X-linked adrenoleukodystrophy and multiple sclerosis. J Neuroimmunol 75:174-182
44. Kobayashi T, Shinnoh N, Kondo A, Yamada T (1997) Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 232:631-636
45. Lu J-F, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, Smith KD (1997) A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci USA 94:9366-9371
46. Suzuki K, Suzuki K (1995) The twitcher mouse: a model for Krabbe disease and for experimental therapies. Brain Pathol 5:249-258
47. Ohno M, Komiyama A, Martin PM, Suzuki K (1993) MHC class II antigen expression and T-cell infiltration in the demyelinating CNS and PNS of the twitcher mouse. Brain Res 625:186-196
48. Matsushima GK, Taniike M, Glimcher LH, Grusby MJ, Frelinger JA, Suzuki K, Ting JPY (1994) Absence of MHC class II molecules reduces CNS demyelination, microglia/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell 78:645-656
49. Bradl M, Bauer J, Flügel A, Wekerle H (2005) Complementary contribution of CD4 and CD8 T lymphocytes to T cell infiltration of the intact and the degenerative spinal cord. Am J Pathol 166:1441-1450
50. Ip CW, Kroner A, Bendszus M, Leder C, Kobsar I, Fischer S, Wiendl H, Nave K-A, Martini R (2006) Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J Neurosci 26:8206-8216
51. Neumann H, Wekerle H (1998) Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J Neuropathol Exp Neurol 58:1-9
52. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM (1993) Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551-560
53. Lafaille J, Nagashima K, Katsuki M, Tonegawa S (1994) High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor mice. Cell 78:399-408
54. + T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med 188:1883-1894
55. + T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J Exp Med 188:1875-1882
56. + donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG -/- mice. J Neurosci Res 71:89-103
57. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238
58. Garcia KC, Radu CG, Ho J, Ober RJ, Ward ES (2001) Kinetics and thermodynamics of T cell receptor-autoantigen interactions in murine experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 98:6818-6823
59. Wekerle H (2006) Breaking ignorance: the case of the brain. In: Radbruch A, Lipsky PE (eds) Current concepts in autoimmunity and chronic inflammation. Springer, Berlin, pp 25-50
60. Kamradt T, Göggel R, Erb KJ (2005) Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol 26:260-267
61. Waldner H, Collins M, Kuchroo VK (2004) Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest 113:990-997
62. + cells. J Immunol 175:959-966
63. Storch MK, Stefferl A, Brehm U, Weissert R, Wallström E, Kerschensteiner M, Olsson T, Linington C, Lassmann H (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8:681-694
64. Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK (2003) Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 197:1073-1081
65. Wensky AK, Furtado GC, Garibaldi Marcondes MC, Chen SH, Manfra D, Lira SA, Zagzag D, Lafaille JJ (2005) IFN-γ determines distinct clinical outcomes in autoimmune encephalomyelitis. J Immunol 174:1416-1423
66. k mice. J Immunol 163:1115-1118
67. + T cells in a model for multiple sclerosis. J Exp Med 194:669-676
68. + T cells maintain tolerance to myelin basic protein by 'epitope theft'. Nat Immunol 5:606-614
69. Cornet A, Savidge TC, Cabarrocas J, Deng WL, Colombel JF, Lassmann H, Desreumaux P, Liblau RS (2001) Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? Proc Natl Acad Sci USA 98:13306-13311
70. Cabarrocas J, Bauer J, Piaggio E, Liblau R, Lassmann H (2003) Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes. Eur J Immunol 33:1174-1182
71. Madsen LS, Andersson EC, Jansson L, Krogsgaard M, Andersen CB, Engsberg J, Strominger JL, Svejgaard A, Holmdahl R, Wucherpfennig KW et al (1999) A humanized model for multiple sclerosis using HLA DR2 and a human T cell receptor. Nat Genet 23:343-347
72. Ellmerich S, Takács K, Mycko M, Waldner H, Wahid F, Boyton RJ, Smith PA, Amor S, Baker D, Hafler DA et al (2004) Disease-related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis. Eur J Immunol 34:1839-1848
73. Ellmerich S, Mycko M, Takács K, Waldner H, Wahid FN, Boyton RJ, King RHM, Smith PA, Amor S, Herlihy AH et al (2005) High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model. J Immunol 174:1938-1946
74. Quandt JA, Baig M, Yao K, Kawamura K, Huh J, Ludwin SK, Bian H-J, Bryant M, Quigley L, Nagy ZA et al (2004) Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129 specific humanized TCR transgenic mice. J Exp Med 200:223-234
75. Browning JL (2006) B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat Rev Drug Discov 5:564-576
76. Lassmann H, Brück W, Lucchinetti C (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7:115-121
77. Keegan M, König F, McClelland R, Brück W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M et al (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366:579-582
78. Litzenburger T, Fässler R, Bauer J, Lassmann H, Linington C, Wekerle H, Iglesias A (1998) B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med 188:169-180
79. Bettelli E, Baeten D, Jäger A, Sobel RA, Kuchroo VK (2006) Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 116:2393-2402
80. Krishnamoorthy G, Lassmann H, Wekerle H, Holz A (2006) Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J Clin Invest 116:2385-2392
81. Penhale WJ, Farmer A, McKenna RP, Irvine WJ (1973) Spontaneous thyroiditis in thymectomized and irradiated Wistar rats. Clin Exp Immunol 15:225-236
82. + immunoregulatory T cells in the induction of autoimmune gastritis. Immunol Cell Biol 80:567-573
83. + regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3:135-142
84. + T reg cells impinge on autoimmune diabetes. J Exp Med 202:1387-1397
85. Kim JM, Rasmussen JP, Rudensky AY (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8(2):191-197
86. + regulatory T cells induces a scurfy-like disease. J Exp Med 204(1):57-63
87. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431-440
88. Papiernik M, De Moraes ML, Pontoux C, Vasseur F, Penit C (1998) Regulatory CD4 T cells: expression of IL-2R α chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 10:371-378
89. Li MO, Sanjabi S, Flavell RA (2006) Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25:455-471
90. Akassoglou K, Probert L, Kontogeorgos G, Kollias G (1997) Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 158:348-445
91. Taupin V, Renno T, Bourbonnière L, Rodriguez M, Owens T (1997) Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-α in the central nervous system. Eur J Immunol 27:905-913
92. Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B (1996) Targeted CNS expression of interferon-γ in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 7:354-370
93. Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, Rockenstein EM, Mucke L (1995) Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Am J Pathol 147:53-67
94. Tani M, Fuentes ME, Peterson JW, Trapp BD, Durham SK, Loy JK, Bravo R, Ransohoff RM, Lira SA (1996) Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. J Clin Invest 98:529-539
95. Chen S-C, Leach MW, Chen YY, Cai XY, Sullivan L, Wiekowski M, Dovey-Hartman BJ, Zlotnik A, Lira SA (2002) Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes. J Immunol 168:1009-1017
96. + monocytes and enhanced Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Neurovirology 9:623-636
97. Imamoto K (1986) Appearance of hematogenous cells in the white matter of myelin-deficient Jimpy mice. Arch Histol Jpn 49:297-307
98. Billings-Gagliardi S, Nunnari JN, Nadon NL, Wolf MK (1999) Evidence that CNS hypomyelination does not cause death of jumpy-msd mutant mice. Dev Neurosci 21:473-482
99. Carenini S, Mäurer M, Werner A, Blazyca H, Toyka KV, Schmid CD, Raivich G, Martini R (2001) The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in P0. J Cell Biol 152:301-308
100. Schmid CD, Stienekemeier M, Oehen S, Bootz F, Zielasek J, Gold R, Toyka KV, Schachner M, Martini R (2000) Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci 10:729-735
101. Kobsar I, Berghoff M, Samsam M, Wessig C, Maurer M, Toyka KV, Martini R (2003) Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1. Brain 126:804-813
102. Mastronardi FG, Ackerley CA, Arsenault L, Roots BI, Moscarello MA (1993) Demyelination in a transgenic mouse: a model for multiple sclerosis. J Neurosci Res 36:315-324
103. Waldner H, Whitters MJ, Sobel RA, Collins M, Kuchroo VK (2000) Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc Natl Acad Sci USA 97:3412-3417
104. Mendel I, Natarajan K, Ben Nun A, Shevach EM (2004) A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein. J Neuroimmunol 149:10-21
105. Liu GY, Fairchild PJ, Smith RM, Prowle JR, Kioussis D, Wraith DC (1995) Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407-415
106. Pearson CI, Van Ewijk W, McDevitt HO (1997) Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J Exp Med 185:583-599
107. Huseby ES, Sather B, Huseby PG, Goverman J (2001) Age-dependent T cell tolerance and autoimmunity to myelin basic protein. Immunity 14:471-481
108. Martini R, Toyka KV (2005) Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients. Lancet 3:457-465